Related Experiment Video
Updated: Aug 6, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Postprandial Glycemic Control With Automated Insulin Delivery With Control-IQ Technology: The Impact of Meal
Marco Marigliano1, Claudia Piona1, Elisa Morotti1
1Section of Pediatric Diabetes and Metabolism, Department of Surgery, Dentistry, Pediatrics, and Gynecology, University of Verona, Verona, Italy.
Aims:
To evaluate the efficiency of the AID system with Control-IQ technology and carbohydrate counting (CHC)-based premeal bolus to control postprandial glucose (PPG) after mixed meals with different macronutrient compositions in adolescents with type 1 diabetes (T1D).
Material And Methods:
In this prospective crossover study, 25 adolescents with T1D using an automated insulin delivery (AID-Tandem Tslim X2 with Control-IQ) consumed three iso-caloric meals (745 kcal) on separate days: a standard meal (56.5% carbohydrate), a high-fat (HF) meal (45.9% fat), and a high-protein (HP) meal (24.4% protein). A CHC-based bolus was administered 15 min before each meal. Continuous glucose monitoring metrics and AID insulin delivery were assessed over 6 h. The primary outcome was 6-h time in range (TIR, 70-180 mg/dL).
Results:
Six-hour TIR was significantly lower after HF (65.2%) and HP meals (49.9%) compared with the standard meal (84.3%) (p < 0.01 and p < 0.001, respectively). Postprandial glucose exposure (AUC above 140 and 180 mg/dL) was significantly higher after HF and HP meals at both 3 and 6 h. The AID system delivered significantly more insulin than the pre-programmed basal for HF (+26% at 6 h, p < 0.05) and HP meals (+55% at 6 h, p < 0.001), without increasing hypoglycemia.
Conclusions:
Despite a substantial autonomous increase in insulin delivery, AID systems using Control-IQ technology and a standard CHC-based pre-meal bolus have not achieved adequate postprandial glycemic control after HF and HP meals. Proactively timed, meal-specific insulin strategies are required to improve postprandial outcomes after nutritionally complex meals.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...